Patient Organisation funding and support
Transparency is at the heart of our approach when working with patient organisations, and the interests of patients always come first.
Patient organisations (also referred to as Patient Advisory Groups (PAGs), Healthcare Charities or Patient Groups) can take many forms, but largely aim to improve the lives of people with a particular disease or medical condition. As well as supporting their activities, working with patient organisations can help us have a better understanding of the specific needs of patients and how we can better support these needs.
In providing funding or working with patient organisations, Pfizer’s guiding principle is to ensure that the organisation’s independence is never compromised. We feel passionately that relationships with patient organisations are both valuable and essential, and by operating with a high degree of transparency, we can be confident and proud of the relationships we have developed.
As a member of The Association of the British Pharmaceutical Industry (ABPI), we declare a list of patient organisations to which we provide financial support and/or significant non-financial support, including a description of the nature of the support and its monetary value. For significant non-financial support which cannot be assigned a meaningful monetary value, we are required to describe clearly the value that the organisation receives.
The contributions provided to patient organisations’ work in order to help, or to advocate for, people affected by a particular condition are listed below. In addition, where there is a common purpose, we sometimes identify areas on which we are able to collaborate or partner on specific projects.
The activity types you will find described are: Charitable donation; Corporate sponsorship; Expenses; Benefit in kind; Consultancy and services fees; Research Collaboration.
We disclose the payment of expenses relating to accommodation and travel (both in the UK and abroad) incurred by patient organisations in the course of their interaction with us. Our disclosure of expenses payments for patient organisations includes both out-of-pocket expenses reimbursed to patient groups, and expenses paid in advance by Pfizer.
Currency: where payments were made to a patient organisation in a currency other than GBP, the amount has been reported in GBP; the reported amount was calculated using the average currency exchange rate for the month in which the payment was made
We are always mindful of the potential to create an over-dependency on any funding we provide. That is why, wherever possible, we report the percentage of each patient organisation’s revenue that our funding makes up.
However, there are times when this percentage may be higher than average. This might be due to a difficult fundraising climate, because an organisation is new or small in size, or perhaps experienced some unforeseen circumstances that impacted on its ability to attract income. Where this is the case, we actively encourage the organisation to seek and secure other sources of sustainable funding in line with the guidelines outlined in the ABPI Code of Practice.
Patient organisation disclosure reports